Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth.

Craniosynostosis and supernumerary teeth most often occur as isolated developmental anomalies, but they are also separately manifested in several malformation syndromes. Here, we describe a human syndrome featuring craniosynostosis, maxillary hypoplasia, delayed tooth eruption, and supernumerary teeth. We performed homozygosity mapping in three unrelated consanguineous Pakistani families and localized the syndrome to a region in chromosome 9. Mutational analysis of candidate genes in the region revealed that all affected children harbored homozygous missense mutations (c.662C>G [p.Pro221Arg], c.734C>G [p.Ser245Cys], or c.886C>T [p.Arg296Trp]) in IL11RA (encoding interleukin 11 receptor, alpha) on chromosome 9p13.3. In addition, a homozygous nonsense mutation, c.475C>T (p.Gln159X), and a homozygous duplication, c.916_924dup (p.Thr306_Ser308dup), were observed in two north European families. In cell-transfection experiments, the p.Arg296Trp mutation rendered the receptor unable to mediate the IL11 signal, indicating that the mutation causes loss of IL11RA function. We also observed disturbed cranial growth and suture activity in the Il11ra null mutant mice, in which reduced size and remodeling of limb bones has been previously described. We conclude that IL11 signaling is essential for the normal development of craniofacial bones and teeth and that its function is to restrict suture fusion and tooth number. The results open up the possibility of modulation of IL11 signaling for the treatment of craniosynostosis.

[1]  C. P. Morris,et al.  Unravelling the molecular control of calvarial suture fusion in children with craniosynostosis , 2007, BMC Genomics.

[2]  G. Wise,et al.  Mechanisms of Tooth Eruption and Orthodontic Tooth Movement , 2008, Journal of dental research.

[3]  J. Utsunomiya,et al.  Osteomatous changes and tooth abnormalities found in the jaw of patients with adenomatosis coli. , 1981, Oral surgery, oral medicine, and oral pathology.

[4]  T. Martin,et al.  The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures , 1996, The Journal of experimental medicine.

[5]  D. Rice,et al.  Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development. , 1997, Bone.

[6]  T. Martin,et al.  Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. , 1998, Endocrinology.

[7]  David A. Williams,et al.  Murine interleukin‐11 (IL‐11) is expressed at high levels in the hippocampus and expression is developmentally regulated in the testis , 1996, Journal of cellular physiology.

[8]  T. Imamura,et al.  Mechanical stress induces Interleukin-11 expression to stimulate osteoblast differentiation. , 2009, Bone.

[9]  K. Haavikko Hypodontia of permanent teeth. An orthopantomographic study. , 1971, Suomen Hammaslaakariseuran toimituksia = Finska tandlakarsallskapets forhandlingar.

[10]  Y. Yang,et al.  Interleukin-11 and its receptor. , 1992, BioFactors.

[11]  T. Yin,et al.  Interleukin (IL)‐11‐mediated Signal Transduction a , 1995, Annals of the New York Academy of Sciences.

[12]  K Lange,et al.  Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. , 1996, American journal of human genetics.

[13]  T. Martin,et al.  Molecular mechanisms in coupling of bone formation to resorption. , 2009, Critical reviews in eukaryotic gene expression.

[14]  M. Owen,et al.  Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia , 1997, Cell.

[15]  D. Rice Craniofacial anomalies: from development to molecular pathogenesis. , 2005, Current molecular medicine.

[16]  Ruili Li,et al.  Interleukin‐11 Receptor Signaling Is Required for Normal Bone Remodeling , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  S. Takeda,et al.  Interleukin-11 as a Stimulatory Factor for Bone Formation Prevents Bone Loss with Advancing Age in Mice* , 2002, The Journal of Biological Chemistry.

[18]  Mone Zaidi,et al.  Osteoclast signalling pathways. , 2005, Biochemical and biophysical research communications.

[19]  M. Sasamata,et al.  Synergism between interleukin-11 and bone morphogenetic protein-2 in the healing of segmental bone defects in a rabbit model. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[20]  F. Segal,et al.  A CHARACTERIZATION OF FIBRANT SEGAL CATEGORIES , 2006, math/0603400.

[21]  K. Miyata,et al.  Interleukin-11 induces osteoblast differentiation and acts synergistically with bone morphogenetic protein-2 in C3H10T1/2 cells. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[22]  D. Rice,et al.  Locate, condense, differentiate, grow and confront: developmental mechanisms controlling intramembranous bone and suture formation and function. , 2008, Frontiers of oral biology.

[23]  S. Kreiborg,et al.  Development of the dentition in cleidocranial dysplasia. , 1990, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[24]  C. Begley,et al.  Cloning of a murine IL‐11 receptor alpha‐chain; requirement for gp130 for high affinity binding and signal transduction. , 1994, The EMBO journal.

[25]  Mark A. Hall,et al.  Interleukin-11 Signals through the Formation of a Hexameric Receptor Complex* , 2000, The Journal of Biological Chemistry.

[26]  W. Birchmeier,et al.  Continuous tooth generation in mouse is induced by activated epithelial Wnt/β-catenin signaling , 2006, Proceedings of the National Academy of Sciences.

[27]  G. Ciliberto,et al.  Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions. , 1998, The Biochemical journal.

[28]  A. Tumber,et al.  The cellular actions of interleukin-11 on bone resorption in vitro. , 1998, Endocrinology.

[29]  D. Graves,et al.  Developmentally regulated monocyte recruitment and bone resorption are modulated by functional deletion of the monocytic chemoattractant protein-1 gene. , 2002, Bone.

[30]  M. Passos-Bueno,et al.  Genetics of craniosynostosis: genes, syndromes, mutations and genotype-phenotype correlations. , 2008, Frontiers of oral biology.

[31]  J. Guénet,et al.  Etl2, a novel putative type-I cytokine receptor expressed during mouse embryogenesis at high levels in skin and cells with skeletogenic potential. , 1994, Developmental biology.

[32]  G. Karsenty,et al.  Cbfa1 is required for epithelial-mesenchymal interactions regulating tooth development in mice. , 1999, Development.

[33]  Henry Rj,et al.  Supernumerary and congenitally absent teeth: a literature review. , 1996, The Journal of clinical pediatric dentistry.

[34]  N. Sims gp130 signaling in bone cell biology: Multiple roles revealed by analysis of genetically altered mice , 2009, Molecular and Cellular Endocrinology.

[35]  C. Begley,et al.  Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation , 1998, Nature Medicine.

[36]  P. Nieminen Genetic basis of tooth agenesis. , 2009, Journal of experimental zoology. Part B, Molecular and developmental evolution.

[37]  Gillian M Morriss-Kay,et al.  Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies , 2005, Journal of anatomy.

[38]  N. Athanasou,et al.  Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. , 2002, Bone.

[39]  Peter J. Park,et al.  Apc inhibition of Wnt signaling regulates supernumerary tooth formation during embryogenesis and throughout adulthood , 2009, Development.

[40]  T. Yamashiro,et al.  Runx2 mediates FGF signaling from epithelium to mesenchyme during tooth morphogenesis. , 2004, Developmental biology.

[41]  Gillian M Morriss-Kay,et al.  Skeletal analysis of the Fgfr3P244R mouse, a genetic model for the Muenke craniosynostosis syndrome , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[42]  J. Heath,et al.  Identification of Three Distinct Receptor Binding Sites of Murine Interleukin-11* , 1999, The Journal of Biological Chemistry.

[43]  C. Dickson,et al.  A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  P. Römer,et al.  The molecular mechanism behind bone remodelling: a review , 2009, Clinical Oral Investigations.

[45]  A. Giraud,et al.  Cytokine signalling via gp130 in gastric cancer. , 2009, Biochimica et biophysica acta.

[46]  Robert B. Hartlage,et al.  This PDF file includes: Materials and Methods , 2009 .

[47]  G. Rogler,et al.  Functional Expression of the Interleukin-11 Receptor α-Chain and Evidence of Antiapoptotic Effects in Human Colonic Epithelial Cells* , 2004, Journal of Biological Chemistry.

[48]  S. Ho,et al.  Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.

[49]  U. Lerner,et al.  Characterization of the bone-resorptive effect of interleukin-11 in cultured mouse calvarial bones. , 2002, Bone.

[50]  A. Roberts,et al.  Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis. , 2007, Blood.

[51]  K. Miyata,et al.  Interleukin-11 acts synergistically with bone morphogenetic protein-2 to accelerate bone formation in a rat ectopic model. , 2003, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[52]  S. Marks,et al.  Tooth eruption: Theories and facts , 1996, The Anatomical record.

[53]  S. Pruzansky,et al.  Craniosynostosis : diagnosis, evaluation, and management , 1986 .

[54]  P. Heinrich,et al.  Identification of the domain in the human interleukin-11 receptor that mediates ligand binding. , 2001, Journal of molecular biology.

[55]  C. Begley,et al.  Adult mice with targeted mutation of the interleukin-11 receptor (IL11Ra) display normal hematopoiesis. , 1997, Blood.

[56]  J. Karras,et al.  STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. , 2008, Journal of Clinical Investigation.